Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$21.5M
3 rounds on record
Latest round
$12M
Seed · Feb 2024 · 2 yr ago
Team
6
US Form 5500 (plan participants) · Dec 2025 · 0% in a year
Revenue
$25M
2022 · SEC Form D 0001969222-23-000001
Backers
2
Playground, venBio Partners
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 26, 2024
Launched Insamo launches to develop cyclic peptides · Chemical & Engineering News
Feb 25, 2024
Raised a round Seed $12M · Pulse 2.0
Mar 8, 2023
Raised a round Venture round $9.5M · SEC Form D
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Feb 2024 | $12M | — | Pulse 2.0 |
| Debt Financing | Dec 2023 | $2.3M | — | SEC Form D |
| Venture round | Mar 2023 | $9.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | INSAMO INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Timothy CravenExecutive Officer, DirectorSEC Form D
Toby PassiouraExecutive Officer, DirectorSEC Form D
Glen McintyreExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Aqemia is a Paris company founded in 2019 that designs drug candidates with quantum-inspired statistical physics and deep learning. Its…

immunitoAI is an AI-driven biotechnology company accelerating antibody discovery and the development of antibody-based therapies through…

KisoJi Biotechnology. Breakthrough antibody discovery forbreakthrough therapeutics.

Custom affinity reagents, designed for your target and application. Medium Biosciences designs experimentally validated affinity reagents…

Advanced Antibody Design Services. Macromoltek harnesses the power of computational modeling and artificial intelligence to accelerate and…

We are building a system which accurately represents knowledge and uncertainty, to enable the discovery of insights and transparent problem…
Overview
Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
News
Jung Jun-ha stuns fans with surprise 'Insamo' reunion stage on Hangout With Yoo
Jung Jun-ha stuns fans with surprise Insamo reunion stage on Hangout With Yoo Hangout With Yoo moved everyone with the Insamo gathering of unpopular
Read more
Report
Yoo Jae-suk, surprised by 'Insamo' fan devotion…
Members of 'Insamo (Association of Unpopular People)' finally come face to face with their hidden fans. On the December 27 broadcast of MBC variety show 'How Do You Play?' (directed by Kim Jin-yong...
Read more
Report
Insamo South Pty Ltd,
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Insamo South Pty Ltd, reflects the research output of authors from Insamo South Pty Ltd, who published articles in the 145 journals in
Read more
Report
Insamo launches to develop cyclic peptides
Chemical & Engineering News (C&EN): Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People

Timothy Craven
Executive Officer, Director

Toby Passioura
Executive Officer, Director

Glen Mcintyre
Executive Officer, Director

Corey Goodman
Director

Matt Hershenson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Berkeley
United States
HQ
50-200 est. staff

Playground
venBio Partners